Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.41 -0.05%   SPY: 165.31 -0.09%
Quote Spy NLTX NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Nile Therapeutics (NLTX)

@ May-23
Click the portfolio to add NLTX:
Close [X]
+ Add NLTX to Portfolio
  
  Last Trade: $0.08 0.00 (0.00%)
  Volume: 19,800 44% of avg daily volume
       
  Avg Volume: 45,030
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 0.08 - 0.08
  Open: 0.08
  Previous Close: 0.08
  52-wk Range: 0.02 - 0.25
  Market Cap: 3.5M
  P/E: -0.8
  Div Yield: $0.00 (0.00%)
Indexes
None
Spy NLTX

? Pro holders
? Member holders
? Items submitted
Additional NLTX resources



Customize Links
To see which Pros and tickerspy members own NLTX Sign up now
Latest NLTX Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Nile Therapeutics Reports 2009 Fourth Quarter and Full Year Financial Results
NLTX  
Linked by BusinessWire - March 03, 08:30AM from (www.businesswire.com)
Nile Therapeutics, Inc. (NASDAQ:NLTX), a biopharmaceutical company in the development of novel therapeutics for heart failure  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Nile Therapeutics Reports 2009 Third Quarter Financial Results
NLTX  
Linked by BusinessWire - November 12, 05:00PM from (www.businesswire.com)
Nile Therapeutics, Inc. (NASDAQ: NLTX), a company focused on the development of novel therapeutics for heart failure patients,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Nile Therapeutics downgraded to "neutral"
NLTX  
Linked by newratings - March 30, 12:43PM from (www.newratings.com)
NEW YORK, March 30 (newratings.com) - Analysts at Ladenburg Thalmann downgrade Nile Therapeutics (ticker: NLTX) from "buy"  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Nile Therapeutics "buy," target price raised
NLTX  
Linked by newratings - November 14, 12:43PM from (www.newratings.com)
NEW YORK, November 14 (newratings.com) - Analysts at Maxim Group reiterate their "buy" rating on Nile Therapeutics  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource